Furthermore, high expression levels of NF-κB were associated with more advanced disease stages and poorer overall patient survival in ccRCC, suggesting that NF-κB may influence the TME and patient clinical outcomes by inducing apoptosis in dysfunctional CD8 + T cells [313]. The gene discussed is NFKB1; the disease is nonpapillary renal cell carcinoma.